Compulink Showcases Innovative Mobile Patient Engagement Technology at AUA 2018

09:00 EDT 17 May 2018 | Businesswire

Compulink Business Systems, Inc.

Company demonstrates mobile phone app to engage with patient by texting personalized content

Compulink Business Systems, Inc., a leader in specialty specific EHR and Practice Management solutions, will demonstrate the latest enhancements to Urology Advantage™ at this week’s American Urological Association’s Annual Meeting. Among the key innovations being demonstrated is a solution to engage patients with a state-of-the-art mobile experience.

Advantage’s mobile Patient Engagement app allows for delivery of personalized content to the patient’s phone via a text message. Content can be targeted based on the patient’s appointment type and diagnosis. The app can be used to market products and services, along with delivering patient education. Surveys can also be sent to the patient’s phone and the feedback collected is automatically brought back into Advantage for analysis.

Used by more than 10,000 providers nationwide, Compulink’s ONC 2015 Certified all-in-one system is designed to streamline practice workflow and drive efficiency and profitability. Features include urology-specific EHR, Practice Management, RCM, AUA assessments, analytics, patient engagement, telehealth, and audit protection.

Attendees at AUA 2018 can demo Urology Advantage at booth #5872 from May 19-21 in San Francisco, CA.

About Compulink

A proven partner for 33 years, Compulink is a leader in specialty specific EHR and Practice Management solutions. We provide everything you need to deliver value-based care and achieve financial success. For more information, visit

Compulink Business Systems, Inc.
Mary Ann Fitzhugh
p. 800.456.4522


More From BioPortfolio on "Compulink Showcases Innovative Mobile Patient Engagement Technology at AUA 2018"

Quick Search


Relevant Topic

Antiretroviral therapy
Standard antiretroviral therapy (ART) consists of the combination of at least three antiretroviral (ARV) drugs to maximally suppress the HIV virus and stop the progression of HIV disease. Huge reductions have been seen in rates of death and suffering whe...